Miso Clinic · Clinical column

Cheek sagging — we start by asking what has descended

In the faces of people who arrive saying “my cheeks have sagged”, what has actually changed is usually not the skin. Cheek sagging is, in most cases, not stretched skin but descended fat compartments, and tightening the skin and addressing what has descended aim at different things. And the thickness of what is being addressed varies greatly between people.

Clinical column About a 12-minute read September 2026 Miso Clinic, Daegu · Dr. Lee Chi-Hak

The short answer

Cheek sagging is usually not “skin that has stretched” but “fat compartments that have descended”. Tightening skin and addressing what has descended therefore aim at different targets. One fact is easy to miss here — the thickness of what is being addressed differs greatly from person to person. In measurements of 53 cadavers, facial skin thickness was relatively even across regions at 1.51 to 1.97 mm, while superficial fat ranged from 1.61 to 5.14 mm, roughly a 3.2-fold difference. In other words, the variation between individuals and between regions is larger than the 1.5 mm adjustment step of a focused ultrasound cartridge. And the data on what actually predicted response runs against the common assumption — in Sasaki 2007 (25 patients, 12-month follow-up), the only predictor of response was tissue mobility; skin thickness and fat depth did not predict response. Age was not reported as a significant factor either.

What cheek sagging actually is

Four different changes sit inside the single phrase cheek sagging. Which one has changed decides which approach points in the right direction.

Four changes called cheek sagging and the approach that matches each
What changedWhat it looks likeApproach that points the right way
Descent of fat compartmentsThe area above the nasolabial fold thickens and the jawline blursTightening or lifting — radiofrequency, focused ultrasound, threads
Loss of fat itselfThe front of the cheek hollows and casts a shadowFilling — tightening does not fill it
Thinning of the dermisTexture breaks down and light reflects unevenlyInjectables — collagen boosters
Bone resorptionThe supporting structure recedesReinforcement — but the volume required grows

In most faces these four are mixed together. That is why there is no single answer called “the treatment for cheek sagging”. How settings diverge with thickness and fat volume is set out in lifting has to change with skin thickness and fat volume.

What is not the answer

“Radiofrequency fills a hollow cheek.” Lost volume is not filled by heat. Radiofrequency and focused ultrasound act on the dermis and the structures beneath it with heat, and sagging is what that addresses. A hollow belongs to the filler class.

“A booster lifts cheek sagging.” Collagen boosters target the density and texture of the dermis. Sagging is a problem of structure and position, not of dermal density, so the direction differs.

“More shots means more lift.” A “shot” is not a dose the operator chooses; it is a discharge count sealed into the single-use tip in advance. The endpoint set by the manufacturer is not a shot count either but the heat the patient feels. This is set out in how many shots are needed.

“It has sagged a lot, so a device will handle it.” Laxity that requires surgical excision of excess skin is outside the range of non-invasive devices. Not blurring that boundary is the first step of the consultation.

On combining treatments — objectively

“Wouldn’t it be better to do them together?” comes up often in consultation. The sentence is intuitively plausible but not supported by the data. Precisely stated — “combining them works better” was not confirmed in the two randomised trials.

When we do plan treatments alongside each other, the reason is not that it is better but that the layers being addressed are different — dermal density (injectables) and the sagging of the structures beneath it (devices) are separate problems to begin with, and many people have both. So we design a sequence, not a package. What comes first and what comes later is decided by the goal, the downtime, and whether it can be reversed. This is set out in booster first, or lifting first.

How thick the evidence is, by class

What has been confirmed for each class used in cheek sagging, and its limits
ClassWhat has been confirmedLimits
Radiofrequency (RF)A 2026 systematic review covering 15 studies and 1,230 patientsOne randomised controlled trial; no meta-analysis was performed because of heterogeneity; no head-to-head study between devices was identified
Focused ultrasound (HIFU)Creates point coagulation zones at set depthsAnatomical variation is larger than the cartridge adjustment step of 1.5 mm
Individual devicesXERF 20 patients · Density 16 patients · Oligio 20 patientsNone of the three had a control group
ThreadsThe level of evidence is thinDifficult to reverse

We could not identify a study that put the two technologies against each other under the same conditions. That situation is set out in HIFU and radiofrequency.

The order we look in consultation

  1. We compare lying down with sitting up. How much returns on lying down is a clue to how much has descended.
  2. We assess tissue mobility. It was the only predictor of response in Sasaki 2007 — not skin thickness and not fat depth.
  3. We separate what is hollow from what has descended. Mixing the two leads to the wrong choice of treatment.
  4. We say first if it is outside the non-invasive range. If the degree of laxity calls for excision, we say so.
  5. We set the point of judgment in advance. For radiofrequency, clinician assessment was not significant at 4 weeks and was significant at 12 weeks, with the peak at 4 to 6 months.

Frequently asked questions

Is lifting the answer for cheek sagging?

If what has descended is the main problem, the direction is right. If a hollow is the main problem, tightening does not fill it. Making that distinction first is what keeps the choice of treatment from going wrong.

Does thin skin respond better to lifting?

In Sasaki 2007 (25 patients, 12 months), skin thickness and fat depth did not predict response. The only predictor was tissue mobility. That said, in thin skin epidermal protection carries more weight in the design, so the settings differ.

Does it work less well at an older age?

In Sasaki 2007, age was not reported as a significant factor. Differences across age groups in general are set out in what changes about lifting in your thirties, forties and fifties.

Is it better to use several devices?

No head-to-head study between devices was identified, and “combining them works better” was not confirmed in the two randomised trials either. When we do combine, it is because the layers addressed are different, not because more is better.

Can it be done in one session?

The meaning of a session differs by class, and trials that compare different session counts are themselves scarce. We decide the next step from the state of the tissue, not from the calendar.

Which clinic in Daegu is good for cheek sagging?

There is no public metric comparing operator skill. It is more useful to ask “in my case, has it descended or has it hollowed?” and choose the clinic whose answer is specific.

Who wrote this

Written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu, South Korea. Every study cited above is given together with its design, its size and the limitations the authors themselves recorded, and where we could not find data, we have said that we could not find any.

Miso Clinic
Medical directorLee Chi-Hak, MD
Address4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea · Exit 1, Kyungpook National University Hospital Station
Phone+82-53-428-2700
HoursWeekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays
ColumnsAll clinical columns
Reference libraryAll booster and device references

References

  1. Measurements of 53 cadavers — facial skin thickness 1.51 to 1.97 mm, superficial fat 1.61 to 5.14 mm (about a 3.2-fold difference); anatomical variation exceeds the 1.5 mm cartridge adjustment step of focused ultrasound
  2. Sasaki 2007 (25 patients, 12 months) — the only predictor of response was tissue mobility; skin thickness, fat depth and age were not reported as significant factors
  3. 2026 systematic review — radiofrequency lifting, 15 studies and 1,230 patients, one randomised controlled trial; no head-to-head study between devices was identified
  4. Blinded-evaluator study in 20 Korean women — radiofrequency: clinician assessment not significant at 4 weeks, significant at 12 weeks, peak at 4 to 6 months

Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.

← Clinical columns · Reference library · Miso Clinic home

한국어 · English · 日本語 · 简体中文 · Español · Tiếng Việt · ภาษาไทย · Bahasa Indonesia